Abivax S.A. ABVX 深 滬
已收盤 07-25 16:00:00 美东时间
66.49
-3.270
-4.69%
華盛通- 最 高70.25
- 今 開67.975
- 成交量 354.02万股
- 最 低 65.87
- 昨 收 69.76
- 總市值 42.14亿
- 52周最高 72.90
- 市盈率 靜 --
- 換手率 5.59%
- 52周最低 4.77
- 委 比 -53.28%
- 總股本 6338.33万
- 歷史最高 72.90
- 量 比 0.41
- 振 幅 6.28%
- 歷史最低 4.77
- 每 手 1
- 風險率 5.79%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股周涨跌榜 | 本周飙升568%！Abivax S.A.新药III期研究成功；CRO股Medpace周涨超43%
本周飙升568%！生物技术公司Abivax S.A.溃疡性结肠炎口服药物III期研究成功；CRO股Medpace周涨超43%，Q2营收和EBITDA均超预期>>
07-26 10:23
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)
Abivax, a clinical-stage biotech company developing treatments for chronic inflammatory diseases, has announced that underwriters for its offering of 10,156,000 ADSs have fully exercised their option to purchase an additional 1,523,400 ADSs. This brings the total ADSs issued to 11,679,400 and gross proceeds to $747.5 million (€637.5 million). The additional ADSs are priced at $64.00 each, reflecting a 21% premium over the average price of ordinar...
07-25 06:00
美股牛股 | 肠炎新药临床试验进展积极，ABVX飙涨超580%！ANEB大涨超80%
肠炎新药临床试验进展积极，ABVX飙涨超580%！公司宣布高溢价私有化计划，ANEB大涨超80%>>
07-24 19:53
Abivax launches $400M ADS offering
Abivax (NASDAQ:ABVX) has launched a public offering of American Depositary Shares (ADSs) in the U.S. to raise approximately $400 million (€340 million). Each ADS represents one ordinary share of the c...
07-24 14:26
Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares
Abivax has announced a $650 million public offering of American Depositary Shares (ADSs), each representing one ordinary share. The offering is priced at $64.00 per ADS, with proceeds to be used primarily for clinical development of obefazimod for Ulcerative Colitis and Crohn’s Disease, as well as general corporate purposes. The offering may dilute existing shareholders by up to 18.4%. Risks include immediate dilution, future sales depressing sha...
07-24 12:40
美股大行评级 | 瑞银上调微软(MSFT)目标价升至600美元；花旗维持Unity 买入"评级，目标价从29美元升至44美元
今日重点评级关注：瑞银：维持泰尼特"买入"评级，目标价从230美元升至238美元；杰富瑞：维持BellRing Brands"买入"评级，目标价从80美元升至82美元
07-24 09:49
Why Is Abivax Stock (ABVX) Up 490% Today?
Abivax stock rocketed higher on Wednesday after it posted positive Phase 3 clin...
07-24 08:36
Abivax announces temporary trading halt of its ordinary shares on Euronext Paris
Abivax temporarily halted trading of its ordinary shares on Euronext Paris starting July 24, 2025, at 9:00 a.m. CEST. The suspension, requested by the company, aims to facilitate the confirmation of allocations and pricing for its ongoing public offering of American Depositary Shares (ADS) in the U.S. Trading is expected to resume later the same day at approximately 3:30 p.m. CEST. Abivax, a clinical-stage biotech company focused on immune-modula...
07-24 05:30
美股异动丨Abivax飙升596%，创历史新高
格隆汇7月23日｜法国生物技术公司Abivax(ABVX.US)飙升596%，报69.68美元，创历史新高。消息面上，Abivax宣布其首创新型口服miR-1...
07-23 22:43
Abivax药物试验成果显著 股价飙升逾550%
美东时间周三早间，法国慢性病生物技术公司Abivax（ABVX）股价暴涨逾550%，因其溃疡性结肠炎治疗药物obefazimod三期临床试验取得积极成果。该...
07-23 21:40
